Home / Stocks / CME

CME Group (CME, Exchanges & market data) Stock Valuation & Fair Value Weak on forward returns

CME Group (CME, Exchanges & market data) trades at a current P/E of 23.3, about 12% below its historical normal valuation, with a forward growth estimate of 7.2% and a PEG of 3.26. Analysts' one-year estimates have been hit 73% of the time. Priced at its historical normal P/E of 26.5 on the same blended earnings, the 2026-10-09 close of $280.56 corresponds to about $319 a share. This is a valuation reference, not a price target.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation and forecast return, and for the top ratings, credit rating, growth and analyst accuracy.

DATA AS OF 2026-10-12
Current P/E
23.3
Normal P/E
26.5
PEG
3.26
Fwd growth
7.2%
Div yield
1.9%
RSI (14)
58.0
Neutral
Technical context
  • Price $277.24 at the 2026-10-12 close, 2.6% above the 20-day average ($270.15) and 2.2% above the 50-day ($271.32).
  • RSI (14) at 58.0.
  • 52-week range $217.56 to $315.71: the price is 12.2% below the high and 27.4% above the low.

The Street vs SeerForecast

Wall Street's mean price target for CME is $289.06 across 16 analysts, 4.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: weak on forward returns. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been weak on forward returns since 2026-06-03.

Current P/E and rating by weekCurrent P/E moved from 23.9 to 23.3 between 2026-06-03 and 2026-10-09, against a normal P/E of 26.5, with 2 rating changes over 39 recorded weeks.2026-06-03: P/E 23.9, Weak on forward returns, recalculated for the week of 2026-06-032026-06-10: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-06-102026-06-12: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-06-142026-06-16: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-06-162026-06-18: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-06-212026-07-02: P/E 19.7, Mixed on our tests, recalculated for the week of 2026-07-022026-07-06: P/E 20.2, Weak on forward returns, recalculated for the week of 2026-07-062026-07-09: P/E 20.2, Weak on forward returns, recalculated for the week of 2026-07-092026-07-10: P/E 20.5, Weak on forward returns, recalculated for the week of 2026-07-122026-07-13: P/E 20.5, Weak on forward returns, recalculated for the week of 2026-07-132026-07-14: P/E 20.5, Weak on forward returns, recalculated for the week of 2026-07-142026-07-20: P/E 20.9, Weak on forward returns, recalculated for the week of 2026-07-202026-07-22: P/E 20.9, Weak on forward returns, recalculated for the week of 2026-07-222026-07-24: P/E 21.7, Weak on forward returns, recalculated for the week of 2026-07-252026-07-27: P/E 21.7, Weak on forward returns, recalculated for the week of 2026-07-272026-07-31: P/E 22.7, Weak on forward returns, recalculated for the week of 2026-07-312026-07-31: P/E 22.7, Weak on forward returns, recorded live 2026-08-032026-08-07: P/E 22.4, Weak on forward returns, recalculated for the week of 2026-08-072026-08-07: P/E 22.3, Weak on forward returns, recorded live 2026-08-102026-08-14: P/E 22.6, Weak on forward returns, recalculated for the week of 2026-08-142026-08-14: P/E 22.8, Weak on forward returns, recorded live 2026-08-172026-08-21: P/E 22.8, Weak on forward returns, recalculated for the week of 2026-08-212026-08-21: P/E 23.2, Weak on forward returns, recorded live 2026-08-242026-08-27: P/E 23.2, Weak on forward returns, recalculated for the week of 2026-08-272026-08-28: P/E 23.6, Weak on forward returns, recalculated for the week of 2026-08-282026-08-28: P/E 24.1, Weak on forward returns, recalculated for the week of 2026-08-302026-08-28: P/E 24.1, Weak on forward returns, recorded live 2026-08-312026-09-04: P/E 23.6, Weak on forward returns, recalculated for the week of 2026-09-052026-09-04: P/E 23.6, Weak on forward returns, recorded live 2026-09-072026-09-11: P/E 23.1, Weak on forward returns, recalculated for the week of 2026-09-122026-09-11: P/E 23.1, Weak on forward returns, recorded live 2026-09-142026-09-18: P/E 23.1, Weak on forward returns, recalculated for the week of 2026-09-192026-09-18: P/E 23.1, Weak on forward returns, recorded live 2026-09-212026-09-25: P/E 22.1, Weak on forward returns, recalculated for the week of 2026-09-262026-09-25: P/E 22.1, Weak on forward returns, recorded live 2026-09-282026-10-02: P/E 22.0, Weak on forward returns, recalculated for the week of 2026-10-032026-10-02: P/E 22.0, Weak on forward returns, recorded live 2026-10-052026-10-09: P/E 23.3, Weak on forward returns, recalculated for the week of 2026-10-102026-10-09: P/E 23.3, Weak on forward returns, recorded live 2026-10-1220.022.024.026.0Jun 3Jul 5Aug 6Sep 7Oct 9Normal P/E 26.5
Mixed on our testsWeak on forward returns

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 23.9-10%Weak on forward returns (recalculated)
2026-07-02P/E 19.7-26%Mixed on our tests (recalculated)
2026-07-06P/E 20.2-24%Weak on forward returns (recalculated)
2026-08-30P/E 24.1-9%Weak on forward returns (recalculated)
2026-10-12P/E 23.3-12%Weak on forward returns ← now
Show all 39 weeks
WeekCurrent P/EPremium to normal P/ERating
2026-06-03P/E 23.9-10%Weak on forward returns (recalculated)
2026-06-10P/E 22.1-17%Weak on forward returns (recalculated)
2026-06-14P/E 22.1-17%Weak on forward returns (recalculated)
2026-06-16P/E 22.1-17%Weak on forward returns (recalculated)
2026-06-21P/E 22.1-17%Weak on forward returns (recalculated)
2026-07-02P/E 19.7-26%Mixed on our tests (recalculated)
2026-07-06P/E 20.2-24%Weak on forward returns (recalculated)
2026-07-09P/E 20.2-24%Weak on forward returns (recalculated)
2026-07-12P/E 20.5-23%Weak on forward returns (recalculated)
2026-07-13P/E 20.5-23%Weak on forward returns (recalculated)
2026-07-14P/E 20.5-23%Weak on forward returns (recalculated)
2026-07-20P/E 20.9-21%Weak on forward returns (recalculated)
2026-07-22P/E 20.9-21%Weak on forward returns (recalculated)
2026-07-25P/E 21.7-18%Weak on forward returns (recalculated)
2026-07-27P/E 21.7-18%Weak on forward returns (recalculated)
2026-07-31P/E 22.7-14%Weak on forward returns (recalculated)
2026-08-03P/E 22.7-14%Weak on forward returns
2026-08-07P/E 22.4-16%Weak on forward returns (recalculated)
2026-08-10P/E 22.3-16%Weak on forward returns
2026-08-14P/E 22.6-15%Weak on forward returns (recalculated)
2026-08-17P/E 22.8-14%Weak on forward returns
2026-08-21P/E 22.8-14%Weak on forward returns (recalculated)
2026-08-24P/E 23.2-12%Weak on forward returns
2026-08-27P/E 23.2-12%Weak on forward returns (recalculated)
2026-08-28P/E 23.6-11%Weak on forward returns (recalculated)
2026-08-30P/E 24.1-9%Weak on forward returns (recalculated)
2026-08-31P/E 24.1-9%Weak on forward returns
2026-09-05P/E 23.6-11%Weak on forward returns (recalculated)
2026-09-07P/E 23.6-11%Weak on forward returns
2026-09-12P/E 23.1-13%Weak on forward returns (recalculated)
2026-09-14P/E 23.1-13%Weak on forward returns
2026-09-19P/E 23.1-13%Weak on forward returns (recalculated)
2026-09-21P/E 23.1-13%Weak on forward returns
2026-09-26P/E 22.1-16%Weak on forward returns (recalculated)
2026-09-28P/E 22.1-16%Weak on forward returns
2026-10-03P/E 22.0-17%Weak on forward returns (recalculated)
2026-10-05P/E 22.0-17%Weak on forward returns
2026-10-10P/E 23.3-12%Weak on forward returns (recalculated)
2026-10-12P/E 23.3-12%Weak on forward returns ← now

Frequently asked questions

Is CME Group stock overvalued?

At a current P/E of 23.3 versus its historical normal P/E of 26.5, CME Group trades about 12% below its typical valuation, with a PEG of 3.26 on 7.2% forward growth. tickerseer currently rates it weak on forward returns.

What is CME Group's fair value and PEG?

CME Group trades at a current P/E of 23.3 against a historical normal P/E of 26.5, a PEG of 3.26, and a forward growth estimate of 7.2%. Priced at its historical normal P/E of 26.5 on the same blended earnings, the 2026-10-09 close of $280.56 corresponds to about $319 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of CME Group changed?

tickerseer's rating has been weak on forward returns since 2026-06-03.

What is the analyst price target for CME Group?

The mean Wall Street price target for CME Group is $289.06 across 16 analysts, 4.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Exchanges & market data. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track CME free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.